Question? Ask Dr. Bikman’s Digital Mind (multilingual): Dr. Bikman’s Community & Coaching Site: https://insuliniq.com (https://insuliniq.com/) Summary: Dr. Bikman explains how insulin resistance may contribute to benign prostatic hyperplasia (BPH), the noncancerous enlargement of the prostate. Although aging and male sex hormones are important, he argues that metabolic health helps explain why prostate growth varies so much among men. He connects that growth to familiar symptoms, including a weaker urine stream and frequent nighttime bathroom trips. Ben reviews observational human studies linking higher fasting insulin, abdominal obesity, diabetes, and metabolic syndrome with larger prostates or faster growth. He describes insulin and IGF-1 as growth signals, then explores how visceral fat, altered sex-hormone metabolism, and chronic inflammation could reinforce the process. Laboratory and animal research support several proposed mechanisms, while human findings on some hormone pathway
Question? Ask Dr. Bikman’s Digital Mind (multilingual): Dr. Bikman’s Community & Coaching Site: https://insuliniq.com (https://insuliniq.com/) In this mini lecture, Dr. Ben Bikman introduces asprosin, a hormone released primarily by fat tissue that helps regulate both blood sugar and hunger. Unlike leptin, which generally signals the brain to reduce appetite, asprosin appears to do the opposite. During fasting, it tells the liver to release glucose into the bloodstream while also activating areas of the brain that encourage eating. These effects may be helpful when food is scarce, but could contribute to metabolic problems when the hormone remains elevated. Ben reviews research showing that asprosin levels are often higher in people with obesity, insulin resistance, and type 2 diabetes. Animal studies suggest that blocking asprosin can reduce hunger, lower blood glucose, and improve metabolic health. However, human research remains limited, and inconsistent laboratory measurements make